We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In order to cut prices of patented medicines for cancer and rare diseases, a government panel in India has made a series of recommendations including granting "compulsory licenses" to any domestic pharmaceutical company to produce drugs without the consen